go to contents

3D Spine Matrix Biotechnologie GmbH

Back to list

Facts

Founded
2016
Staff
2
Organization type
RDM biotech/pharma
Region
Lower Austria
Focus
human health
Focus
other

Profile

Sales/Distribution:The company conservatively assumes that the general rate of substitution using disc-maintaining therapy will be 10% of the market. This would lead to a market potential of approx. 30.000 applications. With an average implant price of € 1.770, as attained according to company assumptions, this results in a adressable market potential in Europe of at least € 53 million.

Similar companies in RDM biotech/pharma

OncoLab Diagnostics GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
ecoplus
Focus
human health
Details

PLANTA Naturstoffe Vertriebsges.m.b.H.

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Sandoz GmbH

Organization type
RDM biotech/pharma
Region
Tyrol
Cluster
Life Sciences Tyrol
Focus
human health
Details

Orpha Trade GmbH

Organization type
RDM biotech/pharma
Region
Lower Austria
Cluster
LISAvienna
Focus
human health
Details

Contact

Magnesitstraße 1
3500 Krems
Lower Austria

Contact: Axel Krabler (CEO)
Email: management@spine-matrix.com
Website